Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully

Suven Pharmaceuticals Limited's Active Pharmaceutical Ingredients (API) and Formulations facilities (Unit-3 and Unit-5, respectively) in Pashamylaram, Hyderabad, India, have completed the PreApproval Inspections (PAI) and Good Manufacturing Practices (GMP) inspections by the US Food & Drug Administration (US FDA) today. The inspection was conducted from February 12, 2024, to February 23, 2024, and no Form 483 has been issued as a result of the inspection.

Remedium Lifecare to consider acquisition of manufacturing facility near Hyderabad

A meeting of the Board of Directors of Remedium Lifecare Ltd is scheduled on 07/03/2024, to consider and approve the acquisition of manufacturing facility near hyderabad, producing intermediates for the Pharmaceutical Industry.

Kilitch Drugs India’s subsidiary wins tender from Ethiopia

Kilitch Estro Biotech PLC, subsidiary of Kilitch Drugs (India) Limited has received intimation today i.e. Friday, 23rd February, 2024 that the Kilitch Estro Biotech PLC has won the tender issued by The Federal Democratic Republic of Ethiopia Pharmaceutical Supply Service for supply of Pharmaceuticals. The contract price is USD 91,31,715.36.